Revance Therapeutics, Inc. (RVNC)

Trade RVNC now with
9/6/2017 7:34:50 AM Revance Therapeutics Appoints Mark Foley To Board
3/7/2017 8:11:36 AM Revance Therapeutics Completes Patient Enrollment In Two Pivotal Trials Of SAKURA Phase 3 Program
2/28/2017 7:30:17 AM William Blair Reiterates Revance Therapeutics, Inc. (RVNC) At Outperform
11/3/2016 8:16:41 AM Revance Therapeutics Says Begins Phase 2 Trial Of RT002 Injectable To Treat Plantar Fasciitis